SCHEMBL15467345

SCHEMBL15467345

Cc1ccc(C2(NC(=O)c3ccccc3)CCOc3cccnc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.53
RAB9A P51151 9/20 0.37
NPC1 O15118 8/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
ADORA3 P0DMS8 1/20 0.35
DYRK1A Q13627 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
RCE1 Q9Y256 1/20 0.35
PTGS2 P35354 1/20 0.35
AKT1 P31749 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15467342 1.00 TRPM8 (0.53) TRPM8RAB9ANPC1MEN1KMT2A
SCHEMBL15467040 0.93 TRPM8 (0.54) TRPM8RAB9ANPC1MEN1KMT2A
SCHEMBL15469407 0.93 TRPM8 (0.52) TRPM8RAB9ANPC1SMN1; SMN2POLB
SCHEMBL15469410 0.91 TRPM8 (0.51) TRPM8RAB9ANPC1MEN1KMT2A
SCHEMBL15469370 0.91 TRPM8 (0.55) TRPM8RAB9ANPC1KMT2APOLB
SCHEMBL15467015 0.90 TRPM8 (0.52) TRPM8RAB9ANPC1MEN1KMT2A
SCHEMBL15467108 0.90 TRPM8 (0.54) TRPM8RAB9ANPC1MEN1KMT2A
SCHEMBL15467016 0.90 TRPM8 (0.52) TRPM8RAB9ANPC1MEN1KMT2A
SCHEMBL15467106 0.90 TRPM8 (0.54) TRPM8RAB9ANPC1MEN1KMT2A
SCHEMBL15467675 0.89 TRPM8 (0.57) TRPM8RAB9ANPC1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952009-B2 Chroman derivatives as TRPM8 inhibitors AMGEN INC. (US) 2015-02-10 US claimed
WO-2014025651-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC. (US) 2014-02-13 WO claimed
US-20140045855-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC. (US) 2014-02-13 US claimed
US-8952009-B2 Chroman derivatives as TRPM8 inhibitors AMGEN INC. (US) 2015-02-10 US disclosed
US-8952009-B2 Chroman derivatives as TRPM8 inhibitors AMGEN INC. (US) 2015-02-10 US disclosed
US-20150031668-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC (US) 2015-01-29 US disclosed
US-20150031668-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC (US) 2015-01-29 US disclosed
WO-2014025651-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC. (US) 2014-02-13 WO disclosed
US-20140045855-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC. (US) 2014-02-13 US disclosed
US-20140045855-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC. (US) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031668-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS TRPM8, TRPM5, TRPM7 TRPM8 1/4885RAB9A 1056/4885NPC1 702/4885
US-20140045855-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS TRPM8, TRPM5, TRPM7 TRPM8 1/4885RAB9A 1056/4885NPC1 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.